Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $40,000 | 1 | 97.7% |
| Food and Beverage | $938.43 | 14 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $40,055 | 2 | $0 (2023) |
| Penumbra, Inc. | $312.87 | 2 | $0 (2024) |
| Boston Scientific Corporation | $140.40 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $114.30 | 1 | $0 (2023) |
| Silk Road Medical, Inc. | $112.90 | 1 | $0 (2023) |
| UCB, Inc. | $42.82 | 2 | $0 (2024) |
| Catalyst Pharmaceuticals, Inc. | $39.65 | 1 | $0 (2023) |
| Lundbeck LLC | $28.61 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $24.90 | 1 | $0 (2024) |
| ABBVIE INC. | $23.87 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $595.29 | 9 | Penumbra, Inc. ($312.87) |
| 2023 | $343.14 | 5 | AstraZeneca Pharmaceuticals LP ($114.30) |
| 2022 | $40,000 | 1 | Medtronic, Inc. ($40,000) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: PSYCHIATRY | ||||||
| 08/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Central Nervous System | ||||||
| 08/27/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $165.02 | General |
| Category: Neurointervention | ||||||
| 07/16/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $28.61 | General |
| Category: NEUROLOGY | ||||||
| 05/23/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $140.40 | General |
| Category: WATCHMAN_IC | ||||||
| 05/21/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $147.85 | General |
| Category: Neurointervention | ||||||
| 03/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/13/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $20.12 | General |
| Category: Neurology | ||||||
| 12/19/2023 | Medtronic, Inc. | SOLITAIRE X (Device) | Food and Beverage | In-kind items and services | $55.21 | General |
| Category: Stents | ||||||
| 12/14/2023 | Lilly USA, LLC | AMYVID (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Neuroscience | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $114.30 | General |
| Category: Rare Disease | ||||||
| 10/17/2023 | Silk Road Medical, Inc. | ENROUTE Transcarotid Stent (Device), ENROUTE Transcarotid Neuroprotection System | Food and Beverage | In-kind items and services | $112.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2023 | Catalyst Pharmaceuticals, Inc. | FIRDAPSE (Drug) | Food and Beverage | Cash or cash equivalent | $39.65 | General |
| Category: NEUROLOGY | ||||||
| 10/04/2022 | Medtronic, Inc. | CHIKAI 008 (Device) | Grant | Cash or cash equivalent | $40,000.00 | General |
| Category: Access | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 185 | 195 | $66,349 | $22,996 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 63 | 64 | $26,560 | $8,782 | 33.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 25 | 28 | $15,960 | $4,773 | 29.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 31 | $8,773 | $3,186 | 36.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 23 | 25 | $5,325 | $2,355 | 44.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $4,995 | $1,959 | 39.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 29 | 32 | $4,736 | $1,941 | 41.0% |
About Dr. Alexander Senetar, DO
Dr. Alexander Senetar, DO is a Vascular Neurology healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2018. The National Provider Identifier (NPI) number assigned to this provider is 1457856320.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alexander Senetar, DO has received a total of $40,938 in payments from pharmaceutical and medical device companies, with $595.29 received in 2024. These payments were reported across 15 transactions from 12 companies. The most common payment nature is "Grant" ($40,000).
As a Medicare-enrolled provider, Senetar has provided services to 185 Medicare beneficiaries, totaling 195 services with total Medicare billing of $22,996. Data is available for 1 year (2023–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Vascular Neurology
- Location Sarasota, FL
- Active Since 03/24/2018
- Last Updated 07/31/2023
- Taxonomy Code 2084V0102X
- Entity Type Individual
- NPI Number 1457856320
Products in Payments
- CHIKAI 008 (Device) $40,000
- Penumbra System (Device) $312.87
- WATCHMAN Access System (Device) $140.40
- ANDEXXA (Biological) $114.30
- ENROUTE Transcarotid Stent (Device) $112.90
- SOLITAIRE X (Device) $55.21
- FIRDAPSE (Drug) $39.65
- VYEPTI (Biological) $28.61
- REXULTI (Drug) $24.90
- BOTOX (Biological) $23.87
- Zilbrysq (Drug) $22.70
- Austedo XR (Drug) $21.82
- AMYVID (Drug) $21.08
- Rystiggo (Drug) $20.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.